BlackRock Fund Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.4B Buy
19,053,029
+1,423,459
+8% +$106M 0.26% 52
2016
Q3
$1.41B Buy
17,629,570
+423,179
+2% +$33.9M 0.29% 50
2016
Q2
$1.36B Buy
17,206,391
+475,012
+3% +$35.8M 0.3% 49
2016
Q1
$1.2B Buy
16,731,379
+159,487
+1% +$12.1M 0.28% 54
2015
Q4
$1.4B Buy
16,571,892
+592,309
+4% +$49.2M 0.32% 46
2015
Q3
$1.34B Buy
15,979,583
+234,773
+1% +$19.8M 0.35% 41
2015
Q2
$1.31B Sell
15,744,810
-985,517
-6% -$75.1M 0.32% 47
2015
Q1
$1.22B Buy
16,730,327
+79,384
+0.5% +$5.65M 0.29% 52
2014
Q4
$1.15B Buy
16,650,943
+771,916
+5% +$52.1M 0.28% 49
2014
Q3
$1.03B Buy
15,879,027
+411,637
+3% +$26.1M 0.29% 45
2014
Q2
$962M Sell
15,467,390
-278,223
-2% -$16.6M 0.27% 47
2014
Q1
$927M Buy
15,745,613
+115,435
+0.7% +$6.44M 0.27% 46
2013
Q4
$797M Buy
15,630,178
+848,679
+6% +$42.5M 0.24% 55
2013
Q3
$744M Buy
14,781,499
+13,264
+0.1% +$694K 0.25% 49
2013
Q2
$725M Buy
+14,768,235
New +$804M 0.27% 44

Other funds holding LLY

BlackRock Fund Advisors's LLY Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Eli Lilly (LLY) stake by 8.1% in Q4 2016, buying an estimated $106M and bringing the position to 19,053,029 shares worth $1.4B. The position accounts for 0.26% of the portfolio, ranked #52.

BlackRock Fund Advisors first reported a position in LLY in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.41B in Q3 2016. 1,212 funds tracked by Wall St. Rank hold LLY as of Q4 2016.

  • BlackRock Fund Advisors held 19,053,029 shares of Eli Lilly worth $1.4B as of Q4 2016.
  • BlackRock Fund Advisors bought 1,423,459 Eli Lilly shares in Q4 2016, an estimated $106M.
  • Eli Lilly made up 0.26% of BlackRock Fund Advisors's portfolio in Q4 2016, its #52 holding.
  • BlackRock Fund Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Eli Lilly position peaked at $1.41B in Q3 2016.
  • 1,212 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.